VICC Receives ‘Exceptional’ Score With Renewal as an NCI-Designated Comprehensive Cancer Center
September 29th 2020Vanderbilt-Ingram Cancer Center received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute and places it once again in a top group of NCI Comprehensive Cancer Centers.
Dr. Ciombor on the Goals of the COLOMATE Trial in mCRC
January 31st 2020Kristen Ciombor, MD, MSCI, assistant professor of medicine, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, discusses the goals of the COLOMATE protocol in metastatic colorectal cancer (mCRC).